This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Sluková, D. et al. The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: a magnetic resonance-based study in transgender individuals. J. Clin. Transl. Endocrinol. https://doi.org/10.1016/j.jcte.2024.100379 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carty, S. Metabolic effects of gender-affirming hormone therapy. Nat Rev Endocrinol 21, 134 (2025). https://doi.org/10.1038/s41574-024-01084-7
Published:
Issue date:
DOI: https://doi.org/10.1038/s41574-024-01084-7